EBD-200 presents a surface more similar to that presented by hA and has optimal in vivo asparaginase kinetic properties with no L-GLNase co-activity resulting in an improved toxicity profile compared to PEG-ASNase EBD-200 presents a surface that is significantly more identical to the surface of the human asparaginase homolog compared to the E. coli asparaginase…